| Serial Number | 90144485 |
| Word Mark | ZEAL & ZEALAND PHARMA |
| Filing Date | Friday, August 28, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 21, 2023 |
| Registration Number | 6986947 |
| Registration Date | Tuesday, February 21, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 19, 2021 |
| Goods and Services | (Based on Use in Commerce) Publication of articles and scientific text and posters featuring the results of clinical trials for pharmaceutical preparations related to diabetes, obesity and gastrointestinal diseases; providing educational seminars, educational exhibitions, conferences and training courses, all in the field of diabetes, obesity and gastrointestinal diseases; educational seminars, educational exhibitions, conferences and instructional services relating to medical treatments in the field of diabetes, obesity and gastrointestinal diseases; educational services, namely, organizing and conducting educational programs, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity and gastrointestinal diseases |
| Description of Mark | The mark consists of the wording "ZEAL&" with each letter appearing in white, in a blue circle, an overlapped grey circle, an overlapped yellow circle, an overlapped turquoise circle, a red circle, from left to right, with the grey wording "ZEALAND PHARMA" written below. |
| Goods and Services | (Based on 44(e)) Pharmaceutical preparations for the treatment of diabetes, obesity and gastrointestinal diseases; synthetic peptides for pharmaceuticals purposes for the treatment of diabetes, obesity and gastrointestinal diseases; pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans, namely, pharmaceutical preparations for treating endocrine disorders, immunity disorders, nutritional and metabolic diseases, such as diabetes and obesity; pharmaceutical preparations for the treatment and prevention of hypoglycemia; hypoglycemic agents; medical preparations in the nature of a liquid solution for medical purposes for the treatment and prevention of hypoglycemia; pharmaceutical preparations for treating gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; pharmaceutical preparations altering the immune system, such as complement inhibitors; apparatus and instruments containing pharmaceutical preparations, substances and medicines; medical rescue injection pens containing glucagon to treat severe cases of low blood sugar; pre-filled syringes for medical purposes containing insulin or glucagon or analogues of those |
| Goods and Services | (Based on Use in Commerce) printed pharmaceutical information leaflets in the field of diabetes, obesity and gastrointestinal diseases; printed publications, namely, books, magazines, periodicals and manuals, all in the field of diabetes, obesity and gastrointestinal diseases; printed instructional or teaching matter in the field of diabetes, obesity and gastrointestinal diseases; printed instructional and teaching materials about diagnosing and treatment of diabetes, obesity and gastrointestinal diseases; printed guidelines for diagnosing and treatment of diabetes, obesity and gastrointestinal diseases |
| Pseudo Mark | ZEAL AND ZEALAND PHARMACY; ZEAL AND ZEALAND PHARMACEUTICALS |
| Indication of Colors claimed | The color(s) grey, yellow, turquoise, red, white and blue is/are claimed as a feature of the mark. |
| Goods and Services | (Based on 44(e)) Marketing services; customer relationship management; business administrative services for medical referrals; patient relationship management services; business administration of pharmacy and pharmaceutical benefit plans |
| Goods and Services | (Based on 44(e)) Licensing of patent and intellectual property rights arising from medical and pharmaceutical research and development activities; licensing of proprietary intellectual property |
| Goods and Services | (Based on 44(e)) Medical analysis services for the diagnosis and treatment of humans; medical consulting services in the field of diseases, illnesses and ailments in humans; medical services related to the testing and treatment of patients with diabetes or low blood sugar (hypoglycemia); medical services related to testing and treatment of patients with gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; clinical trials; medical consulting services, namely, providing patient adherence programs to patients suffering from diabetes, obesity or gastrointestinal diseases; providing web-based on-line portals that provide a patient adherence program to patients suffering from diabetes, obesity or gastrointestinal diseases; medical information services, namely, providing information relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical advisory services, namely, providing advisory services relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical services in the nature of patient support relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical information and advice in relation to treatment planning, including information and advice provided via the Internet, databases and application software; consultancy services relating to the aforesaid |
| Goods and Services | (Based on Use in Commerce) Medical apparatus and instruments, namely, diabetes management devices, infusion and injection devices, infusion pumps, infusion pump controllers and parts and attachments thereof; medical devices and sensors used to continuously monitor the concentration of glucose in the human body; blood glucose monitors for medical purposes; glucose monitor accessories, namely, transmitters, receivers, and medical sensor insertion devices; wearable medical devices for insulin monitoring; infusion pumps for improvement of glycemic control and auto-injector pens for the treatment of hypoglycemia; medical rescue injection pens for administrating glucagon; parts and accessories for all the aforesaid goods; wearable health devices for insulin monitoring |
| Disclaimer with Predetermined Text | "ZEALAND PHARMA" |
| Goods and Services | (Based on 44(e)) Scientific and technological services, namely, research and design in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid; providing scientific information on diabetes, obesity and gastrointestinal diseases; providing websites featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity and gastrointestinal diseases; computer services, namely, providing a website featuring technology that enables users to obtain data concerning medical analysis and management of diabetes, obesity and gastrointestinal diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 1, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 1, 2020 |
| Primary Code | 010 |
| First Use Anywhere Date | Monday, May 31, 2021 |
| First Use In Commerce Date | Monday, May 31, 2021 |
| International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
| US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 1, 2020 |
| Primary Code | 016 |
| First Use Anywhere Date | Monday, May 31, 2021 |
| First Use In Commerce Date | Monday, May 31, 2021 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 1, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 1, 2020 |
| Primary Code | 041 |
| First Use Anywhere Date | Monday, May 31, 2021 |
| First Use In Commerce Date | Monday, May 31, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 1, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 1, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 1, 2020 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Zealand Pharma A/S |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Søborg 2860 DK |
| Party Name | Zealand Pharma A/S |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Søborg 2860 DK |
| Party Name | Zealand Pharma A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Søborg 2860 DK |
| Event Date | Event Description |
| Tuesday, February 21, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, February 21, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, January 14, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, January 13, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Saturday, December 17, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, November 15, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, October 27, 2022 | USE AMENDMENT FILED |
| Tuesday, November 15, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, October 27, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, June 23, 2022 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Thursday, June 9, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 7, 2022 | SOU EXTENSION 1 GRANTED |
| Tuesday, June 7, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, June 7, 2022 | TEAS EXTENSION RECEIVED |
| Friday, February 4, 2022 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, December 14, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 19, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 19, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 29, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, September 13, 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Sunday, September 12, 2021 | ASSIGNED TO LIE |
| Saturday, September 11, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, September 11, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, September 11, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, September 11, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, September 11, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, September 9, 2021 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, September 7, 2021 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Tuesday, August 24, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 24, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 24, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 24, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 24, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 5, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, August 5, 2021 | FINAL REFUSAL E-MAILED |
| Thursday, August 5, 2021 | FINAL REFUSAL WRITTEN |
| Tuesday, August 3, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 3, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 3, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 27, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 27, 2021 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 27, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, June 25, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 25, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 25, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 7, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 7, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, January 7, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 30, 2020 | ASSIGNED TO EXAMINER |
| Friday, October 2, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, October 1, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 1, 2020 | NEW APPLICATION ENTERED |